Christophe Mérieux Dies at 39; LabCorp Names New CEO; Solexa Fills New COO Slot With ABI Vet; and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Christophe Mérieux, bioMérieux's vice president of research and development, died July 14 after a heart attack, according to news reports. He was 39.
 
He was also the head of Transgène, the company's Strasbourg, France-based subsidiary. Transgene said today Michel Dubois would take Mérieux's seat as chairman of the board.
 
His father, Alain Mérieux, currently the CEO, was set to hand over control of the company to him in the next two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.